C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation MK Chung, DO Martin, D Sprecher, O Wazni, A Kanderian, CA Carnes, ... Circulation 104 (24), 2886-2891, 2001 | 1983 | 2001 |
Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation MJ Mihm, F Yu, CA Carnes, PJ Reiser, PM McCarthy, DR Van Wagoner, ... Circulation 104 (2), 174-180, 2001 | 868 | 2001 |
Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation CA Carnes, MK Chung, T Nakayama, H Nakayama, RS Baliga, S Piao, ... Circulation research 89 (6), e32-e38, 2001 | 689 | 2001 |
MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock Q Zhao, X Wang, LD Nelin, Y Yao, R Matta, ME Manson, RS Baliga, ... The Journal of experimental medicine 203 (1), 131-140, 2006 | 467 | 2006 |
Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice DM Weinstein, MJ Mihm, JA Bauer Journal of Pharmacology and Experimental Therapeutics 294 (1), 396-401, 2000 | 326 | 2000 |
Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications SK Wattanapitayakul, JA Bauer Pharmacology & therapeutics 89 (2), 187-206, 2001 | 300 | 2001 |
Endothelial dysfunction and peroxynitrite formation are early events in angiotensin‐induced cardiovascular disorders SK Wattanapitayakul, DM Weinstein, BJ Holycross, JA Bauer The FASEB Journal 14 (2), 271-278, 2000 | 217 | 2000 |
Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure MJ Mihm, CM Coyle, BL Schanbacher, DM Weinstein, JA Bauer Cardiovascular research 49 (4), 798-807, 2001 | 202 | 2001 |
Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents JA Groner, M Joshi, JA Bauer Pediatrics 118 (4), 1683-1691, 2006 | 180 | 2006 |
Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity SK Wattanapitayakul, L Chularojmontri, A Herunsalee, ... Basic & clinical pharmacology & toxicology 96 (1), 80-87, 2005 | 170 | 2005 |
Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear MS Joshi, C Mineo, PW Shaul, JA Bauer FASEB journal: official publication of the Federation of American Societies …, 2007 | 160 | 2007 |
Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism SK Wattanapitayakul, MJ Mihm, AP Young, JA Bauer Trends in pharmacological sciences 22 (7), 361-368, 2001 | 154 | 2001 |
Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease MJ Mihm, DM Amann, BL Schanbacher, RA Altschuld, JA Bauer, KR Hoyt Neurobiology of disease 25 (2), 297-308, 2007 | 149 | 2007 |
Atrial glutathione content, calcium current, and contractility CA Carnes, PML Janssen, ML Ruehr, H Nakayama, T Nakayama, ... Journal of Biological Chemistry 282 (38), 28063-28073, 2007 | 147 | 2007 |
Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase MJ Mihm, F Yu, DM Weinstein, PJ Reiser, JA Bauer British journal of pharmacology 135 (3), 581-588, 2002 | 143 | 2002 |
Mechanisms of nitrate tolerance HL Fung, JA Bauer Nitrates updated: current use in angina, ischemia, infarction and failure, 57-79, 1997 | 139 | 1997 |
Biochemical mechanism of organic nitrate action HL Fung, SJ Chung, JA Bauer, S Chong, EA Kowaluk The American journal of cardiology 70 (8), B4-B10, 1992 | 137 | 1992 |
Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. JA Bauer, HL Fung Circulation 84 (1), 35-39, 1991 | 133 | 1991 |
Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model MJ Mihm, JL Seifert, CM Coyle, JA Bauer Life sciences 69 (5), 527-542, 2001 | 126 | 2001 |
Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage MJ Mihm, L Jing, JA Bauer Journal of cardiovascular pharmacology 36 (2), 182-187, 2000 | 124 | 2000 |